Almira Chabi
About
In The Last Decade
Almira Chabi
9 papers receiving 316 citations
Peers
Comparison fields: 5 of 49
- Ophthalmology 198
- Radiology, Nuclear Medicine and Imaging 164
- Psychiatry and Mental health 61
- Biomedical Engineering 50
- Endocrine and Autonomic Systems 47
Countries citing papers authored by Almira Chabi
This map shows the geographic impact of Almira Chabi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Almira Chabi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Almira Chabi more than expected).
Fields of papers citing papers by Almira Chabi
This network shows the impact of papers produced by Almira Chabi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Almira Chabi. The network helps show where Almira Chabi may publish in the future.
Co-authorship network of co-authors of Almira Chabi
This figure shows the co-authorship network connecting the top 25 collaborators of Almira Chabi. A scholar is included among the top collaborators of Almira Chabi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Almira Chabi. Almira Chabi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 38 | |
| 2 | 13 | |
| 3 | A randomized Phase 2 trial assessing the safety and efficacy of omidenepag isopropyl 0.002% once and twice daily in subjects with primary open-angle glaucoma or ocular hypertension (Spectrum 6) | 1 |
| 4 | 89 | |
| 5 | 39 | |
| 6 | 10 | |
| 7 | 2 | |
| 8 | 40 | |
| 9 | 101 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.